B-complex vitamins
B vitamin combinations lowered homocysteine by about a quarter. In 15 trials, heart attacks and deaths did not change, and stroke fell 10%. In 11 trials, cognitive aging did not change. A pooled analysis found a small drop in stress. In diabetic kidney disease, B vitamins sped kidney decline and doubled vascular events.
- Status
- Dietary supplement in the US.
- Also called
- B complex, B-50, B-100, vitamin B complex, B vitamins, Berocca, stress formula vitamins, folic acid with B6 and B12
- Taken for
- energy, stress, mood, fatigue, memory, brain health, heart health, homocysteine, hangovers, metabolism
Strong several reviews agree · Moderate one review or consistent trials · Limited one or a few small studies · Untested no study in people, listed with what it rests on
Shown to help2
- ModerateShown to improve stress slightly in healthy and at-risk adults over 4 weeks or more, with no change in depression or anxiety. Bayer funded the review.
- LimitedSmall trials found a B complex lengthened time to exhaustion in 32 young adults, and a B, C and mineral product raised self-rated stamina in working men.
Reported risks3
- LimitedLimited evidence: in two Norwegian trials, folic acid with B12 raised cancer from 8.4% to 10.0% and deaths from 13.8% to 16.1% in people with heart disease.Common
- LimitedOne trial found kidney filtration fell faster on B vitamins than placebo in 238 people with diabetic nephropathy, and vascular events or death were twice as common.How often is not known
- LimitedOne trial found heart attack, stroke or sudden coronary death trended higher on folic acid, B12 and B6 than placebo after a heart attack, at the edge of significance.How often is not known
What people take it for, and what was found
Shown to help2
Stress and mood
Shown to improve stress slightly in healthy and at-risk adults over 4 weeks or more, with no change in depression or anxiety. Bayer funded the review.
The numbers and sources
- Effect
- Across trials of 3 or more B vitamins for 4 weeks or longer, stress improved slightly (SMD 0.23, 95% CI 0.02 to 0.45). Depressive symptoms did not significantly change (SMD 0.15, 95% CI -0.01 to 0.32), nor did anxiety (SMD 0.03, 95% CI -0.13 to 0.20) [5].
- Population
- 16 trials with 2,015 participants, healthy and at-risk, 12 pooled [5].
- Sources
- [5]
- Caveats
- Funded by Bayer HealthCare, which sells B-complex products [5].
Energy and fatigue in healthy people
Small trials found a B complex lengthened time to exhaustion in 32 young adults, and a B, C and mineral product raised self-rated stamina in working men.
The numbers and sources
- Effect
- In a double-blind crossover trial, 28 days of a B1, B2, B6 and B12 product (Ex PLUS) raised running time to exhaustion 1.26-fold over placebo (p < 0.05) and lowered blood lactate and ammonia during and after exercise [10]. In 198 employed men given a B complex with vitamin C and minerals or placebo for 28 days, the supplement group rated themselves higher for physical stamina across assessments, and for concentration, mental stamina and alertness after a working day at some time points [11].
- Population
- 32 healthy adults aged 20 to 30, half women [10]. 198 men aged 30 to 55 in full-time work [11].
- Sources
- [10], [11]
- Caveats
- Two small trials of branded products. The second product also held vitamin C and minerals, so the B vitamins' share cannot be separated [11]. Ratings were self-reported, and effects in [11] appeared at some time points and not others.
Not shown to help2
Heart attack, stroke and death
Not shown to change heart attack or death in 15 trials of B6, folic acid or B12. Stroke was about 10% lower.
The numbers and sources
- Effect
- Across 15 trials of vitamins B6, B9 or B12, heart attack (RR 1.02, 95% CI 0.95 to 1.10) and death from any cause (RR 1.01, 95% CI 0.96 to 1.06) did not change. Stroke was lower (RR 0.90, 95% CI 0.82 to 0.99) [1]. In HOPE-2, folic acid, B6 and B12 lowered homocysteine and did not change major cardiovascular events (RR 0.95, 95% CI 0.84 to 1.07) [2].
- Population
- 71,422 participants in 15 trials [1]; 5,522 people aged 55 or older with vascular disease or diabetes, 5 years [2].
- Sources
- [1], [2]
- Caveats
- The Cochrane authors rated heart attack and mortality evidence high quality [1]. Trials tested folic acid, B6 and B12, not full B-complex products.
Memory and cognitive aging
Not shown to change memory or thinking across 11 trials. One trial in older adults with mild cognitive impairment found slower brain shrinkage.
The numbers and sources
- Effect
- Across 11 trials, B vitamins lowered homocysteine by 26% to 28% and did not change memory, speed, executive function or global cognition (z score difference 0.00, 95% CI -0.05 to 0.06) [3]. In one trial in mild cognitive impairment, brain atrophy was 0.76% a year on B vitamins and 1.08% on placebo (P = 0.001) [4].
- Population
- 22,000 participants in 11 trials, mean 2.3 to 5 years [3]; 168 people over 70 with mild cognitive impairment who completed MRI scans, 24 months [4].
- Sources
- [3], [4]
- Caveats
- The atrophy trial measured brain volume, not cognition. Its effect was concentrated in people with homocysteine above 13 µmol/L [4].
Doses studied
HOPE-2 used 2.5 mg folic acid, 50 mg B6 and 1 mg B12 a day [2]. The brain atrophy trial used 0.8 mg folic acid, 0.5 mg B12 and 20 mg B6 a day [4]. The diabetic kidney trial used 2.5 mg folic acid, 25 mg B6 and 1 mg B12 a day [6]. EFSA sets adult tolerable upper intake levels of 12 mg a day for vitamin B6, 1,000 µg for folic acid, 10 mg for nicotinic acid and 900 mg for nicotinamide. It found no adequate data to set one for thiamine, riboflavin, pantothenic acid or biotin, and no defined adverse effects for B12 [7]. For nerve damage from B6, see the vitamin B6 page.
Risks
Reported risks3
Cancer and death after folic acid with B12
Limited evidence: in two Norwegian trials, folic acid with B12 raised cancer from 8.4% to 10.0% and deaths from 13.8% to 16.1% in people with heart disease.
The numbers and sources
- How common
- Common: between 1 in 100 and 1 in 10 people.
- Effect
- Cancer was diagnosed in 10.0% given folic acid with B12 and 8.4% not given it (HR 1.21, 95% CI 1.03 to 1.41). Death from any cause was 16.1% against 13.8% (HR 1.18, 95% CI 1.04 to 1.33), driven mainly by lung cancer. B6 alone was not linked to any significant effect [8].
- Population
- 6,837 people with ischemic heart disease in two Norwegian trials, median 39 months of treatment and 38 months of follow-up [8].
- Sources
- [8]
- Caveats
- Norway did not fortify food with folic acid. Across 15 trials, mortality did not change [1].
Faster kidney decline and more vascular events in diabetic kidney disease
One trial found kidney filtration fell faster on B vitamins than placebo in 238 people with diabetic nephropathy, and vascular events or death were twice as common.
The numbers and sources
- How common
- How often is not known: the sources give no rate.
- Effect
- At 36 months, kidney filtration fell 16.5 mL/min/1.73 m² on B vitamins and 10.7 on placebo (difference -5.8, 95% CI -10.6 to -1.1). Heart attack, stroke, revascularization or death was twice as common (HR 2.0, 95% CI 1.0 to 4.0) [6].
- Population
- 238 people with type 1 or 2 diabetes and diabetic nephropathy at 5 Canadian centers [6].
- Sources
- [6]
- Caveats
- One trial. Dialysis need did not differ (HR 1.1) [6].
More events after a heart attack on folic acid, B12 and B6
One trial found heart attack, stroke or sudden coronary death trended higher on folic acid, B12 and B6 than placebo after a heart attack, at the edge of significance.
The numbers and sources
- How common
- How often is not known: the sources give no rate.
- Effect
- In the group given all three vitamins, recurrent heart attack, stroke or sudden coronary death trended higher than placebo (RR 1.22, 95% CI 1.00 to 1.50, P = 0.05) [9].
- Population
- 3,749 people within 7 days of a heart attack, median 40 months [9].
- Sources
- [9]
- Caveats
- One trial, with an interval touching 1.
- Why limited
- This rests on one trial, of 3,749 people. Strength counts independent studies that agree, so one trial is limited at any size.
Claims tested and not found
- That B vitamins prevent heart attacks by lowering homocysteine. Homocysteine fell and heart attacks did not change [1][2].
- That B vitamins slow cognitive aging. Across 11 trials and 22,000 people, cognition did not differ from placebo [3].
- That B vitamins protect the kidneys in diabetes. Kidney filtration fell faster on B vitamins than placebo [6].
Sources
- Martí-Carvajal AJ, Solà I, Lathyris D, et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database of Systematic Reviews. 2017. https://doi.org/10.1002/14651858.CD006612.pub5
- Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease. New England Journal of Medicine. 2006. https://doi.org/10.1056/NEJMoa060900
- Clarke R, Bennett D, Parish S, et al. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. The American Journal of Clinical Nutrition. 2014. https://doi.org/10.3945/ajcn.113.076349
- Smith AD, Smith SM, de Jager CA, et al. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial. PLoS ONE. 2010. https://doi.org/10.1371/journal.pone.0012244
- Young LM, Pipingas A, White DJ, et al. A Systematic Review and Meta-Analysis of B Vitamin Supplementation on Depressive Symptoms, Anxiety, and Stress: Effects on Healthy and 'At-Risk' Individuals. Nutrients. 2019. https://doi.org/10.3390/nu11092232
- House AA, Eliasziw M, Cattran DC, et al. Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy. JAMA. 2010. https://doi.org/10.1001/jama.2010.490
- European Food Safety Authority. Overview on Tolerable Upper Intake Levels as derived by the Scientific Committee on Food (SCF) and the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Version 11. 2025. https://www.efsa.europa.eu/sites/default/files/assets/UL_Summary_tables.pdf
- Ebbing M, Bønaa KH, Nygård O, et al. Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12. JAMA. 2009. https://doi.org/10.1001/jama.2009.1622
- Bønaa KH, Njølstad I, Ueland PM, et al. Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction. New England Journal of Medicine. 2006. https://doi.org/10.1056/NEJMoa055227
- Lee MC, Hsu YJ, Shen SY, et al. A functional evaluation of anti-fatigue and exercise performance improvement following vitamin B complex supplementation in healthy humans, a randomized double-blind trial. International Journal of Medical Sciences. 2023. https://doi.org/10.7150/ijms.86738
- Kennedy DO, Veasey RC, Watson AW, et al. Vitamins and psychological functioning: a mobile phone assessment of the effects of a B vitamin complex, vitamin C and minerals on cognitive performance and subjective mood and energy. Human Psychopharmacology. 2011. https://doi.org/10.1002/hup.1216